home / stock / onct / onct articles

ONCT Articles, Oncternal Therapeutics Inc. - From 12/26/23

Stock Information
Company Name: Oncternal Therapeutics Inc.
Stock Symbol: ONCT
Market: NASDAQ
Website: oncternal.com
Menu
ONCT ONCT Quote ONCT Short ONCT News ONCT Articles ONCT Message Board
Get ONCT Alerts

News, Short Squeeze, Breakout and More Instantly...
Crude Oil Rises Over 3%; US Home Prices Increase In October | Benzinga

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 100 points on Tuesday. The Dow traded up 0.34% to 37,5...
Oncternal Therapeutics Reports Patient Death In Mid-Stage Blood Cancer Study Treated With Second Dose Level | Benzinga

Oncternal Therapeutics Inc (NASDAQ: ONCT) updated the status of a recent study involving a treatment for relapsed or refractory aggressive B-c...

Dow Gains Over 50 Points; Chicago Fed National Activity Index Increases For November | Benzinga

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 50 points on Tuesday. Following the market opening Tuesday, the ...

Oncternal Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results | Benzinga

SAN DIEGO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (NASDAQ:ONCT), a clinical-stage biopharmaceutical company focused on t...
Oncternal Therapeutics Adds Matthew Smith, M.D., Ph.D. to its Prostate Cancer Scientific Advisory Board | Benzinga

SAN DIEGO, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (NASDAQ:ONCT), a clinical-stage biopharmaceutical company focused on t...

Promising Preclinical Results From Blood Cancer Propel Oncternal To Buy Rating | Benzinga

HC Wainwright has upgraded Oncternal Therapeutics Inc (NASDAQ: ONCT) to Buy from Neutral with a price target of $2. At the European ...

Previous 10 Next 10